Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
about
Functional regulation of phospholipase D expression in cancer and inflammationNuclear factor kappa B role in inflammation associated gastrointestinal malignanciesHelicobacter pylori and interleukin-8 in gastric cancerThe Role of H. pylori CagA in Regulating Hormones of Functional Dyspepsia PatientsPhospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.Cellular and physiological roles for phospholipase D1 in cancer.MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma.MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cellsH. pylori virulence factors: influence on immune system and pathology.Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients.Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice.MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa.PLD1 overexpression promotes invasion and migration and function as a risk factor for Chinese glioma patients.Tissue microarray staining reveals PLD1 and Sp1 have a collaborative, pro-tumoral effect in patients with osteosarcomas.Helicobacter pylori induces cell migration and invasion through casein kinase 2 in gastric epithelial cells.
P2860
Q26829916-0560B2B7-FC59-4BBE-AB0C-B04FA67CA293Q26865584-8C8CA582-FE69-41EE-AD5E-C6D6A12B7704Q26999701-3BF82172-3494-43B1-9C22-459C73B0D8C7Q28079860-38AEE60C-BB64-44C2-9683-CCC72EA273BEQ34044522-59BEE008-C51E-45B1-A99D-6872F6DFBF19Q34044529-389C80C0-6CE1-412A-BCE1-5B1E353F7A19Q35956839-D4859E78-2DC7-4D97-90D3-073AA1CD638EQ37269357-E1212324-6962-4366-A85E-DAB8FB7DF524Q37570942-F68A8D4B-F604-4113-80BF-FBB369258696Q37694665-2D08F252-C8CE-493F-BC53-4820915339ECQ38544635-DBC01D48-2951-4CA9-95FE-6EE8946D960DQ38894005-D01C9F4A-06B0-402B-9856-31F9BF2F2144Q39069525-65BA5FB3-01F8-4668-B661-1536C659EA66Q40257815-78EF7F05-7C2E-45B7-B5FF-6EEB47BD7988Q41343361-CB5DC988-F1D2-4808-958A-79E00DDDD601Q47110348-AF2F7292-3C4E-49AE-9993-607E84BF4589Q48642689-EFCDDC2E-CD37-42EB-A96A-FA23E5309E68
P2860
Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@en
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@nl
type
label
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@en
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@nl
prefLabel
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@en
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Rebamipide abolishes Helicobac ...... asion of gastric cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.358
P407
P577
2012-08-13T00:00:00Z